Angela DeMichele, MD
Abramson Cancer Center at Penn Medicine · University of Pennsylvania
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Angela DeMichele, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:18 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06551116 · QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast CancerAbramson Cancer Center at Penn Medicine · recruiting · HER2-positive Metastatic Breast Cancer · principal investigator
- Ph2NCT04841148 · Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast CancerAbramson Cancer Center at Penn Medicine · active not recruiting · Breast Cancer · principal investigator
- Ph1/Ph2NCT03400254 · Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER")Abramson Cancer Center at Penn Medicine · withdrawn · Breast Cancer · principal investigator
- Ph2NCT03032406 · CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast CancerAbramson Cancer Center at Penn Medicine · active not recruiting · Breast Cancer Stage IIB · principal investigator
- N/ANCT02830282 · Surveillance Markers of Utility for Recurrence After Neoadjuvant Chemotherapy for Breast CancerAbramson Cancer Center at Penn Medicine · completed · Breast Cancer · principal investigator
- N/ANCT02798341 · The Breast Program - Translational Cancer ResourceAbramson Cancer Center at Penn Medicine · active not recruiting · Breast Cancer · principal investigator
- N/ANCT02732171 · PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast CancerAbramson Cancer Center at Penn Medicine · recruiting · Breast Cancer · principal investigator
- N/ANCT02530008 · Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast CancerAbramson Cancer Center at Penn Medicine · active not recruiting · Women With Suspected or Confirmed Recurrent Breast Cancer · principal investigator
- Ph3NCT02513394 · PALbociclib CoLlaborative Adjuvant StudyAlliance Foundation Trials, LLC. · active not recruiting · Breast Cancer · principal investigator
- N/ANCT01153282 · Physical Functional Side Effects of Taxane Chemotherapy for Breast CancerAbramson Cancer Center at Penn Medicine · completed · Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:18 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.